Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy.

PURPOSE To clarify whether complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes are associated with subtypes of polypoidal choroidal vasculopathy (PCV), such as polypoidal choroidal neovascularization (CNV) and typical PCV. METHODS Two hundred eighty-seven patients were categorized as having polypoidal CNV (85 patients) or typical PCV (202 patients) on the basis of indocyanine green angiographic findings. In total, 277 subjects without age-related macular degeneration (i.e., free of PCV and CNV), served as controls. I62V (rs800292) in the CFH gene and A69S (rs10490924) in the ARMS2 gene were genotyped, and case-control studies were performed in subjects with these PCV subtypes. RESULTS The polypoidal CNV group included no subjects homozygous for the A/A genotype of rs800292, whereas 7% of the typical PCV group had this genotype. Case-control studies of polypoidal CNV and typical PCV showed significant differences in all distributions of rs10490924 between these two groups. In contrast, the distributions of rs10490924 did not differ between the typical PCV and control groups. Logistic regression analysis with adjustment for confounding factors showed the distributions of rs10490924 to differ significantly between the controls and polypoidal CNV cases (P = 2.1 × 10(-10); OR, 10.87). The T/T genotype was significantly more common in the polypoidal CNV than in the typical PCV group (P = 3.6 × 10(-14); OR, 19.61). CONCLUSIONS PCV may be genetically divisible into polypoidal CNV and typical PCV. The rs800292 variant of the CFH gene is a potential marker for typical CNV. The rs10490924 variant of the ARMS2 gene was shown to be associated with polypoidal CNV. Typical PCV was not associated with this variant.

[1]  A. Okubo,et al.  Clinical features of early and late stage polypoidal choroidal vasculopathy characterized by lesion size and disease duration , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  T. Nakayama,et al.  Novel mutations of ABCC6 gene in Japanese patients with Angioid streaks. , 2009, Biochemical and biophysical research communications.

[3]  Akira Negi,et al.  LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. , 2007, American journal of ophthalmology.

[4]  E. Boerwinkle,et al.  Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study. , 2008, American journal of hypertension.

[5]  R. Yamada,et al.  ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy. , 2009, American journal of ophthalmology.

[6]  Hiroyuki Shimada,et al.  Clinicopathologic findings in polypoidal choroidal vasculopathy. , 2008, Investigative ophthalmology & visual science.

[7]  A. Thalamuthu,et al.  Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy. , 2008, Investigative ophthalmology & visual science.

[8]  K. Choy,et al.  Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. , 2006, American journal of ophthalmology.

[9]  A. Negi,et al.  Coding variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopathy. , 2009, Ophthalmology.

[10]  Y. Miyake,et al.  Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation , 2002, The British journal of ophthalmology.

[11]  M. Matsumura,et al.  Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy , 2004, British Journal of Ophthalmology.

[12]  K. Matsuo,et al.  CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation. , 2010, Investigative ophthalmology & visual science.

[13]  J. Slakter,et al.  INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY , 1995, Retina.

[14]  M. Yuzawa,et al.  The origins of polypoidal choroidal vasculopathy , 2005, British Journal of Ophthalmology.

[15]  M. Yuzawa,et al.  Correlation Between Indocyanine Green Angiographic Findings and Histopathology of Polypoidal Choroidal Vasculopathy , 2004, Japanese Journal of Ophthalmology.

[16]  Kanji Takahashi,et al.  [Classification and diagnostic criteria of age-related macular degeneration]. , 2008, Nippon Ganka Gakkai zasshi.

[17]  H. Iijima,et al.  Role of complement factor H I62V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy. , 2011, Ophthalmology.